Top Banner
47

Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Dec 25, 2015

Download

Documents

Estella Anthony
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.
Page 2: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Pathophysiology of Immunodeficiency Diseases

Page 3: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Host Defense Mechanisms

• Skin and mucosal barriers• Humoral immunity (B cells, plasma cells, Ab)• Cell-mediated immunity (T cells)• Phagocytosis• Complement

Page 4: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Overview of Immunodeficiency

Disorders.

The defect might beIn the level of

stem cell or

in any otherlevel of tree

Page 5: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Introduction.

• Immunodeficiency diseases are :A diverse spectrum of illnesses due to various abnormalities of the immune system

• Prevalence : Primary (congenital) 1 : 10,000 to 1 : 200,000

present at birth .

Secondary (acquired) is more common .

Page 6: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Origins of Immunodeficiencyo Primary or Congenital

Inherited genetic defects in immune cell development or function, or inherited deficiency in a particular immune component

o Secondary or acquiredA loss of previously functional immunity due to infection, toxicity, radiation, splenectomy, aging, malnutrition, etc.

Page 7: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Primary or acquired. can affect.

Natural immunity (non-specific body defenses).

Acquired immunity. (specific body defenses).

Phagocytic cells.

Complement proteins.

T-cells. B-cells.

Page 8: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Immunodeficiency / Immunocompromised States

Primary– Intrinsic abnormality of one or more components of the

Immune System• >150 Conditions Characterised• Individually, uncommon, but important to recognise• Range from global, overwhelming immune failure ( SCID) to subtle

defects in individual components of function

• 1/ 10,000 live births

Page 9: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Suspecting Immunodeficiency• Look for infections that are:

Frequent

Recurrent/chronic

Unusual organisms: aspergillous, nocardia

Organisms that respond poorly to therapy

Unusual site: liver abcess, brain abcess

Severity of infection

Page 10: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

8 or more ear infectionswithin 1 year

2 or more serious sinus infectionswithin 1 year

2 or more months on antibiotics without resolution

2 or more pneumoniaswithin 1 year

Failure to gain weight or grownormally

Persistent candidiasis after the age of 1 year

Need for I.V. antibiotic to clear infections

2 or more deep-seatedinfections

A family history of Primary Immunodeficiency

Recurrent, deep skin or organ abscesses

1

2

3

4

5

6

7

8

9

10

The Ten Warning Signs of Primary Immunodeficiency

Page 11: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Classification of Primary Immunodeficiency

1. Antibody deficiencies

2. Cellular deficiencies

3. Phagocytic disorders

4. Complement deficiencies

5. Combined Immunodeficiencies

Page 12: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

HUMORAL Immunodeficiencies(B-cell defects)

Page 13: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Common variable immunodeficiency (CVID) X-linked agammaglobulinemia (XLA) Selective IgA deficiency (SIgAd) Selective IgG subclass deficiency (SIgGsd) Hyper IgM syndrome (HIgM) Transient hypogammaglobulinemia of Infancy (THI) Functional antibody deficiency

Antibody deficiencies include:

Page 14: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Early B-cell differentiation .

Lesions can occur at any site in the pathway of B-cell development.B-cell defect could be in any level in the pathway

Page 15: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

B-cell Defect

Onset after maternal antibodies diminishUsually after 5-7 m/o, later childhood to

adulthoodBacteria: pneumococci, staphylococci,

Hemophilus, campylobacter, mycoplasmaVirus: entovirusRecurrent sinopulmonary infections, chronic GI

symptoms, malabsorptions, arthritis, entroviral meningoencephalitis

Page 16: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

X-linked agammaglobulinaemia(bruton)

In X-LA early maturation of B cells fails

Affect malesFew or no B cells in bloodVery small lymph nodes and tonsilsNo IgRecurrent pyogenic infection

Page 17: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Serum IgA level < 10 mg/dl Prevalence :1:700 , the most common PID

Most are asymptomatic , but have Increased rate of respiratory tract infection (R.T.I )

Some have recurrent G.I.T. , Urogenital tract Symptoms

Because of lack of secretion of IgA on the mucous membrane of GIT and respiratory tract

Increased incidence of allergic and autoimmune diseases

Anti - convlusant drugs (phenytoin) may cause secondary deficiency

IgA deficiency

Page 18: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

2- IgA and IgG subclass defeciency

About 20% lack IgG2and IgG4Susceptible to pyogenic infectionResult from failure in terminal

differentiation of B cells

Page 19: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

3- Immunodfeiciency with increased IgM (HIgM)Low or absent levels of IgA, IgG , IgE Production of large amount of IgM

>200mg/dl of polyclonal IgMSusceptible to pyogenic infection Due to inability of B cells to isotype

switchingThey have B cell

Page 20: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

4- Common Variable Immunodeficiency (CVID)

There are defect in T cell signaling to B cellsAcquired agammaglobulinemia in the 2nd or

3rd decade of lifePyogenic infection80% of patients have B cells that are not

functioningB cells are not defective but donot

differentiate into immunoglobulin producing cell and fail to receive signaling from T lymphocytes

Risk of autoimmune disease and malignancy

Page 21: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

5- Hypogamaglobulinaemia of infancy

Due to delay in in IgG synthesis approximately up to 36 months

In normal infants synthesis begins at 3 months

Normal B lymphocytesProbably lack help of T lymphocytes

Page 22: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Immunoglobulin Levels vs. Age

Page 23: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Cellular Immunodeficiencies

Page 24: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Combined immunodeficiency (CID) Severe combined immunodeficiency (SCID) Ataxia-Telangiectasia syndrome (AT) Wiskott-Aldrich syndrome (WAS) DiGeorge syndrome Chronic mucocutaneous candidiasis (CMCC)

Cellular deficiencies include:

Page 25: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

DiGeorge's syndrome

It the most understood T-cell immunodeficienc Also known as congenital thymic

aplasia/hypoplasia Associated with hypoparathyroidism, congenital

heart disease, fish shaped mouth. Defects results from abnormal development of

fetus during 6th-10th week of gestation when parathyroid, thymus, lips, ears and aortic arch are being formed

Page 26: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.
Page 27: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Combined T & B Immunodeficiencies

Page 28: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

SEVERE COMBINED IMMUNODEFICENCY

In about 50% of SCID patients the immunodeficiency is x-linked whereas in the other half the deficiency is autosomal.

Early onset( 2-6 m/o) Lymphopenia((< 2500 in infants) They are both characterized by an absence of T cell and B

cell immunity and absence (or very low numbers) of circulating T .

Very small thymus, no lymph node , no tonsil Patients with SCID are susceptible to a variety of bacterial,

viral, mycotic and protozoan infections.

Page 29: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

The x-linked SCID is due to a defect in gamma-chain of IL-2 also shared by IL-4, -7, -11 and 15, all involved in lymphocyte proliferation and/or differentiation.

The autosomal SCIDs arise primarily from defects in adenosine deaminase (ADA) or purine nucleoside phosphorylase (PNP) genes which results is accumulation of dATP or dGTP, respectively, and cause toxicity to lymphoid stem cells

Page 30: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Ataxia-telangiectasia

A complex of immunologic, neurologic, endocrinologic,

hepatic and cutaneous abnormalities ataxia(10-12y/o) ,telangiectasis (3-6 y/o) Mutation in ATM gene T-cells and their functions are reduced to various

degrees. B cell numbers are normal to low. Low levels of IgA, IgE, high level of IgM There is a high incidence of malignancy, particularly

lymphoreicular & adenocarcinoma

Page 31: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.
Page 32: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Wiskott-Aldrich syndrome(immunodeficiency with thrombocytopenia and eczema)

X-linked xp11.22-11.23WASP ; assemby of actin filaments required for

microvesicle formation downstream of protein kinase C and tyrosine kinase signaling

Low plaletlet, small size platelet

Associated with normal T cell numbers with reduced functions, which get progressively worse.

Page 33: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

IgM concentrations are reduced but IgG levels are normal

Both IgA and IgE levels are elevated.

Boys with this syndrome develop severe eczema,bleeding tendency

They respond poorly to polysaccharide antigens and are prone to pyogenic infection.

Page 34: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Defects of the phagocytic system

Page 35: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

• Defects of phagocytic cells (numbers and/or functions) can lead to increased susceptibility to a variety of infections.

• Bacteria,fungal infection• Skin and mucus membrane

Page 36: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Cyclic neutropenia

Autosomal dominantMutation in ELA2(neutrophil elastase gene2)It is marked by low numbers of circulating

neutrophil approximately every three weeks. The neutropenia lasts about a week during which the patients are susceptible to infection. The defect appears to be due to poor regulation of neutrophil production.

Tx: r-GCSF ( granulocyte stimulating factor)

Page 37: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Severe congenital Neutropenia(Kostman)

Arrest in promyelocyte stageNeutrophil count< 200Mutation ELA2 or HAX1, autosomal recessive

or dominantSevere infections20% prone to AMLTx: r-GCSF

Page 38: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Shwachman Diamond Syndrome

Mutation in SBDS geneDiarrhea, FTT, malabsorption till 4 m/oEczema, recurrent infectionsNeutrophil count< 1000, pancytopeniaRisk of AML

Page 39: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Chronic granulomatous disease (CGD)

• Defect in intra cellular killing• Normal chemotaxis, ingestion• Normal neutrophil count• x-linked (65%)& autosomal recessive• CGD is characterized lymphadenopathy, hepato-

splenomegaly and chronic draining lymph nodes. • In majority of patients with CGD, the deficiency is

due to a defect in NADPH oxidase that participate in phagocytic respiratory burst.

• Infection with catalase positive organism: e coli, staph areus , fungal , nocardia, serratia

Page 40: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Leukocyte Adhesion DeficiencyLAD1, LAD2,LAD3

Autosomal recessive Defect in chemotaxis These molecules are involved in diapedesis and

hence defective neutrophils cannot respond effectively to chemotactic signals.

Neutrophilia >12,000 , with infection >100,000 Delayed umblical cord separation > 2 wk They don't have sign of inflammation such as

swelling, warmth or pus formation

Page 41: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Chediak-Higashi syndrome(granule sorting disorder)

Mutation in lyst geneGiant granule in cytoplasm of neutrophilsRespiratory burst is normal. Associated with NK cell defect, platelet and

neurological disorders

Page 42: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

• Albinism(oculocutaneous)• Repeated infections• Mild bleeding tendency• Peripheral neuropathy• Prone to hemophagocytic syndrome

Page 43: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Disorders of complement system

Page 44: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Complement abnormalities also lead to increased susceptibility to infections.

There are genetic deficiencies of various components of complement system, which lead to increased infections.

The most serious among these is the C3 deficiency which may arise from low C3 synthesis or deficiency in factor I or factor H. 

Defect in classic pathway; AUTOIMMUNE DISEASECongenital deficiency of C5, 6, 7, 8: > 50%

MENINGOCOCCAL or GONOCOCCAL INFECTION( neisseria)

Page 45: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

Hyper IgE (Job) syndrome

Autosomal dominantSymptoms/signs

Coarse facial features/skeletal abnormalitiesRecurrent staph infections

Impetigo (resistant)Pneumonia with pneumatocele formation Elevated IgE, Eosinophilia, Eczema

Page 46: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.
Page 47: Pathophysiology of Immunodeficiency Diseases Host Defense Mechanisms Skin and mucosal barriers Humoral immunity (B cells, plasma cells, Ab) Cell-mediated.

PID - treatments

• Immunoglobulin replacement• Bone Marrow Transplantation• Gene-based therapies• Antimicrobial management and prophylaxis• Nutritional Support• Patient Support Groups